We only have this paper's title and publication details.
Read it at the sourcePhase 1 trial demonstrates the correlation between axi-cel CAR T-cell peak and utomilumab exposure in large B-cell lymphoma, suggesting combined therapeutic dynamics.
Correlation of Axi-cel CAR T-cell Peak With Utomilumab Dose and Peak Exposure
No takes yet. Share an insight, caveat, or question.
Jain et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: